Slideshow: The Role of CGM in Diabetes Management During Pregnancy

Diabetes in pregnancy is known to put both the mother and child at-risk for numerous negative health outcomes, such as preterm delivery, birthweight extremes, congenital anomaly, stillbirth, admission to neonatal intensive care units, and even neonatal death.¹ With 16% of pregnancies globally being impacted by pre-existing or gestational diabetes, managing the condition during pregnancy is essential.²

Continuous glucose monitors (CGM) have become an essential tool in monitoring diabetes, and can likely have a positive impact on disease management during pregnancy. Three posters being presented at the Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting examined the role CGM plays in pregnancy.

References

1. Bapayeva G, Terzic S, Dotlic J, et al. Pregnancy outcomes in women with diabetes mellitus - the impact of diabetes type and treatment. Prz Menopauzalny. 2022;21(1):37-46. doi:10.5114/pm.2022.113781

2. Li A, Brackenridge A. The role of continuous glucose monitoring in pregnancy. Obstet Med. 2022;15(1):6-10. doi:10.1177/1753495X211014716

3. McCloskey S, Biggio JR, Mussarat N, et al. Impact of continuous glucose monitoring on glycemic control in type 1 diabetes in pregnancy. Presented at: Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting; February 10-14, 2024; National Harbor, MD. Poster 882.

4. Shrestha KS, Battarbee AN. Satisfaction with continuous glucose monitoring in pregnant patients with type 1 and type 2 diabetes. Presented at: Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting; February 10-14, 2024; National Harbor, MD. Poster 323.

5. Sauer S, Sanusi A, Fulcher I, et al. Classifying patients based on weekly continuous glucose monitoring metrics and their association with pregnancy outcomes. Presented at: Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting; February 10-14, 2024; National Harbor, MD. Poster 32.